New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator…
Read More »Clinical trial
New Delhi: A new chapter in the fight against the ongoing epidemic of COVID-19 has begun with the Drug Controller…
Read More »New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the…
Read More »